Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cerilliant
Boehringer Ingelheim
UBS
McKinsey
Farmers Insurance
Express Scripts
Deloitte
Baxter

Generated: May 24, 2018

DrugPatentWatch Database Preview

Ritedose Corp Company Profile

« Back to Dashboard

What is the competitive landscape for RITEDOSE CORP, and what generic and branded alternatives to RITEDOSE CORP drugs are available?

RITEDOSE CORP has four approved drugs.



Summary for Ritedose Corp
US Patents:0
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Ritedose Corp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ritedose Corp LEVALBUTEROL HYDROCHLORIDE levalbuterol hydrochloride SOLUTION;INHALATION 203653-003 Mar 22, 2016 AN RX No No ➤ Sign Up ➤ Sign Up
Ritedose Corp ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE albuterol sulfate; ipratropium bromide SOLUTION;INHALATION 202496-001 Oct 1, 2012 AN RX No No ➤ Sign Up ➤ Sign Up
Ritedose Corp LEVALBUTEROL HYDROCHLORIDE levalbuterol hydrochloride SOLUTION;INHALATION 203653-001 Mar 22, 2016 AN RX No No ➤ Sign Up ➤ Sign Up
Ritedose Corp IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075693-001 Jan 26, 2001 AN RX No Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Citi
US Army
US Department of Justice
Teva
Boehringer Ingelheim
Federal Trade Commission
Harvard Business School
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.